Japan Panel OKs Taiho’s GIST Med, ViiV/Janssen’s HIV Combo and More for Approval

Japan’s key health ministry panel gave the blessing to a batch of new drugs and indications for approval on May 30 including Taiho Pharmaceutical’s gastrointestinal stromal tumor (GIST) treatment pimitespib. If all goes without a hitch, they will be approved...read more